Hormone replacement therapy refers to the treatment of the patients with hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones in the body whose levels have become low.
This report contains market size and forecasts of Drugs For Hormonal Replacement in global, including the following market information:
Global Drugs For Hormonal Replacement Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Drugs For Hormonal Replacement Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Drugs For Hormonal Replacement companies in 2021 (%)
The global Drugs For Hormonal Replacement market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Estrogen Hormone Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drugs For Hormonal Replacement include Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck KGaA, Mylan, Bayer, Teva and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs For Hormonal Replacement manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs For Hormonal Replacement Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Drugs For Hormonal Replacement Market Segment Percentages, by Type, 2021 (%)
Estrogen Hormone
Growth Hormone
Thyroid Hormone
Testosterone Hormone
Global Drugs For Hormonal Replacement Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Drugs For Hormonal Replacement Market Segment Percentages, by Application, 2021 (%)
Menopause
Hypothyroidism
Growth Hormone Deficiency
Male Hypogonadism
Other Diseases
Global Drugs For Hormonal Replacement Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Drugs For Hormonal Replacement Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs For Hormonal Replacement revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Drugs For Hormonal Replacement revenues share in global market, 2021 (%)
Key companies Drugs For Hormonal Replacement sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Drugs For Hormonal Replacement sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck KGaA
Mylan
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
ANI Pharmaceuticals
TherapeuticsMD